AMY LEWIS: Open Payments
NPI 1164793246 · MANSFIELD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,371 in 140 payments from 26 companies in 2025. Trend: 2023 $2,204 · 2024 $1,973 · 2025 $2,371
Food & beverage: $2,371
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 62 | $804 |
| SK Life Science, Inc. | 10 | $230 |
| PFIZER INC. | 18 | $179 |
| Amgen Inc. | 3 | $162 |
| UCB, Inc. | 6 | $144 |
| Axsome Therapeutics, Inc. | 5 | $143 |
| Neurelis, Inc. | 5 | $91 |
| Amneal Pharmaceuticals LLC | 5 | $88 |
| Neurocrine BioSciences, Inc. | 4 | $76 |
| Lilly USA, LLC | 3 | $49 |
Products named: QULIPTA, UBRELVY, NURTEC ODT, UPLIZNA, Symbravo, Briviact, VALTOCO, CREXONT.
Industry payments across TX — which companies pay providers there.
